GUANGDONG JIAYING PHARMACEUTICAL CO., LTD

News Guangdong Jiaying Pharmaceutical Co., Ltd

Equities

002198

CNE1000008P1

End-of-day quote Shenzhen S.E. Other stock markets 06:00:00 2024-04-23 pm EDT			5-day change	1st Jan Change
6.7 ^CNY	+0.15%		+0.90%	-7.97%

2023	Announcement of Resolutions of Guangdong Jiaying?s Fifth Extraordinary General Meeting of Shareholders in 2021	CI
2023	Guangdong Jiaying Pharmaceutical Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Announcement of Resolutions of Guangdong Jiaying?s Fifth Extraordinary General Meeting of Shareholders in 2021	Nov. 15	CI
Guangdong Jiaying Pharmaceutical Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-27	CI
Guangdong Jiaying Pharmaceutical Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-25	CI
Guangdong Jiaying Pharmaceutical Co., Ltd. Approves Management Appointments	23-06-19	CI
Resolutions on Supervisor Nomination by Guangdong Jiaying Venture Capital	23-06-16	CI
Guangdong Jiaying Venture Capital Submits Proposals Related to Supervisor Nominations	23-06-05	CI
Guangdong Jiaying Pharmaceutical Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-28	CI
Guangdong Jiaying Pharmaceutical Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-28	CI
Guangzhou Taiping Enterprise Management Partnership (Limited Partnership) signed the Share Transfer Agreement to acquire 5% stake in Guangdong Jiaying Pharmaceutical Co., Ltd from Chen Shaobin for approximately CNY 195 million.	23-02-20	CI
Jiaying Pharma Sees Up to 3,420% Surge in 2022 Profit	23-01-18	MT
Guangdong Jiaying Pharmaceutical Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-27	CI
Guangdong Jiaying Pharmaceutical Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-19	CI
Guangdong Jiaying Pharmaceutical Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-26	CI
Jiaying Pharmaceutical’s Profit Crashes 93% in 2021 Despite Revenue Growth	22-03-14	MT
Guangdong Jiaying Pharmaceutical Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-11	CI
Liu Libiao completed the acquisition of 5.03% stake in Guangdong Jiaying Pharmaceutical Co., Ltd from Huang Zhiyong and Huang Libing.	21-11-07	CI
Chen Shaobin completed the acquisition of 10% stake in Guangdong Jiaying Pharmaceutical Co., Ltd from Chen Yonghong.	21-11-07	CI
Liu Libiao agreed to acquire 5.03% stake in Guangdong Jiaying Pharmaceutical Co., Ltd from Huang Zhiyong and Huang Libing for approximately CNY 210 million.	21-11-01	CI
An unknown buyer agreed to acquire 10% stake in Guangdong Jiaying Pharmaceutical Co., Ltd for approximately CNY 430 million.	21-11-01	CI
Lin Shaobin signed cancelled the acquisition of 8% stake in Guangdong Jiaying Pharmaceutical Co., Ltd from Chen Yonghong, Huang Zhiyong and Huang Libing	21-10-31	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Guangdong Jiaying Pharmaceutical Co., Ltd

Equities

002198

CNE1000008P1

Summary

Filters